Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.

Source:http://linkedlifedata.com/resource/pubmed/id/11535314

Vaccine 2001 Sep 14 19 32 4661-8

Download in:

View as

Triples

General Info

PMID
11535314